RANQELTA (U.S. Trademark Serial Number 97484402) is a United States trademark of Alkermes Pharma Ireland Limited. The goods and services include: Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia . The correspondent is NORM J. RICH of FOLEY & LARDNER LLP.

This trademark was filed on June 30, 2022 as United States Trademark Application Serial Number 97484402. This trademark application is still pending and does not yet have a registration number.

Trademark PTO Status History

July 04, 2022 – NEW APPLICATION ENTERED IN TRAM

–

–

–

–

–

–

–

View full trademark status information at USPTO

Ownership History

Alkermes Pharma Ireland Limited

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.